Research ethics
Is it ethical to do HIV cure research on people who are dying?
Open access · cc by · source: Europe PMC
The authors argue that dying people with HIV can ethically donate samples and their bodies to cure research that cannot help them, provided consent, altruism and vulnerability are handled with care.
Study at a glance
- Design
- Qualitative / archival — Normative research-ethics analysis built on the Emanuel framework and the investigators' experience running the Last Gift study
- N
- No data analysed; the Last Gift study it discusses plans to recruit about 30 participants
- Population
- Terminally ill people living with HIV (prognosis under 6 months) enrolling in HIV cure-related research and rapid research autopsy
- Outcome
- Thesis: end-of-life HIV cure research can be ethical if five domains (consent, exploitation/altruism, benefit–risk, vulnerability, family and community acceptance) are safeguarded
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
They argue consent should be ongoing ('process consent'), handled by someone other than the treating physician, and should stress that the study cannot cure anything. Genuine altruism reduces worries about exploitation because benefit can include fulfilling one's own aims. They reject labelling all dying people as vulnerable, calling that paternalistic, and propose that some interventions (such as latency-reversing agents) could have acceptable risk at the end of life while stem cell transplants would not.
Methodology
The authors describe the Last Gift study, in which terminally ill people with HIV give blood before death and their whole body for a rapid autopsy within 6 hours of death, to study where HIV hides. Using established frameworks for ethical clinical research, they work through five domains: informed consent, exploitation and altruism, the balance of benefits and risks, vulnerability, and acceptance by families and communities.
Limitations
The paper is written by the study's own investigators, so it doubles as a defence of their protocol and may understate problems. Claims that participation has been positive are anecdotal; there is no systematic data on participants' motives or experiences, which the authors themselves call for. Findings from so few dying participants, with varied causes of death, may not generalise to people with HIV in general.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Dying participants can be protected without being treated as unable to choose.
For HIV cure-related research with terminally ill volunteers (blood draws and rapid autopsy), the study's own investigators argue for ongoing 'process consent' taken by someone other than the treating doctor, and reject labelling all dying people as vulnerable as paternalistic; genuine altruism, they argue, weakens exploitation worries.
Evidence for the claim as stated.
Dying participants can be protected without being treated as unable to choose.
For HIV cure-related research with terminally ill volunteers (blood draws and rapid autopsy), the study's own investigators argue for ongoing 'process consent' taken by someone other than the treating doctor, and reject labelling all dying people as vulnerable as paternalistic; genuine altruism, they argue, weakens exploitation worries.
Scope note — Written by the protocol's own investigators; evidence that participation has been positive is anecdotal.
Limits the claim's scope: a different population, assay, or outcome.
History
When this study was placed
Dated entries from the concept change log — when this paper was added or removed as support, challenge, or qualifier on a claim.
Placed as supporting evidence on Research ethics
For HIV cure-related research with terminally ill volunteers (blood draws and rapid autopsy), the study's own investigators argue for ongoing 'process consent' taken by someone other than the treating doctor, and reject labelling all dying people as vulnerable as paternalistic; genuine altruism, they argue, weakens exploitation worries.
Placed as a scope qualifier on Research ethics
For HIV cure-related research with terminally ill volunteers (blood draws and rapid autopsy), the study's own investigators argue for ongoing 'process consent' taken by someone other than the treating doctor, and reject labelling all dying people as vulnerable as paternalistic; genuine altruism, they argue, weakens exploitation worries.
Related papers in this topic
Same topic cluster — not a recommendation engine.